
OHI Stock Forecast & Price Target
OHI Analyst Ratings
Bulls say
Omega Healthcare Investors Inc. has raised its 2025 funds from operations (FFO) estimate to $2.81 per share from $2.78 per share, demonstrating stronger investment volume than previously anticipated. Additionally, the company's normalized FFO estimate has also been increased to $2.95 per share, up from $2.89 per share, after excluding certain non-recurring items, indicating improved operational stability. Furthermore, the stock is performing well with a year-to-date increase of 12%, outperforming the VNQ index, and currently trades near the higher end of its 10-year valuation range, suggesting robust market confidence.
Bears say
Omega Healthcare Investors Inc. faces ongoing operational challenges, which contribute to a negative outlook on the stock, emphasized by the company's current relative valuation. Although adjusted Funds From Operations (FFO) estimates for 2026 show a modest increase to $3.22 per share, this figure surpasses the consensus core FFO estimate of $3.10 per share, indicating a troubling disconnect between growth expectations and current market conditions. The persistent difficulties faced by operators within the healthcare facility sector further complicate the investment landscape, adding to concerns regarding the stability and profitability of Omega's core business model.
This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.
OHI Analyst Forecast & Price Prediction
Start investing in OHI
Order type
Buy in
Order amount
Est. shares
0 shares